Literature DB >> 2981612

Evidence for multiple steps in neoplastic transformation of normal and preneoplastic Syrian hamster embryo cells following transfection with Harvey murine sarcoma virus oncogene (v-Ha-ras).

D G Thomassen, T M Gilmer, L A Annab, J C Barrett.   

Abstract

Neoplastic development of Syrian hamster embryo (SHE) cells in culture is a multistep process in which intermediate or preneoplastic cells can be identified and isolated. In an attempt to further characterize normal and preneoplastic cells, we have compared their susceptibilities to neoplastic transformation following transfection with cloned DNA of the oncogenic virus, Harvey murine sarcoma virus (HaMSV). Normal SHE cells, which are stably nontumorigenic when injected in nude mice, are competent to take up and express exogenous DNA as demonstrated by transfection experiments with pSV2-neo DNA and certain viral DNAs. SHE cells treated with 5 micrograms of HaMSV DNA per dish remained nontumorigenic. Colonies of SHE cells, isolated after cotransfection with HaMSV and pSV2-neo DNA and selection for G418 antibiotic resistance, expressed Harvey murine sarcoma virus oncogene (v-Ha-ras) RNA and were initially morphologically altered; however, all colonies senesced when subcultured. In contrast, transfection of the cells with polyoma virus DNA alone or HaMSV DNA plus MC29 viral DNA (pSVv-myc) and then injection of the cells into nude mice resulted in progressively growing tumors of hamster origin within 3 to 5 weeks. A preneoplastic cell line, DES-4, isolated after treatment of SHE cells with the human carcinogen diethylstilbestrol, was chosen for comparative analyses. These immortalized cells are nontumorigenic and excellent recipients for exogenous DNA. In contrast to SHE cells, DES-4 cells were highly susceptible to neoplastic transformation following transfection with HaMSV DNA. To further investigate the role of HaMSV DNA in the neoplastic transformation of DES-4 cells and to determine whether this occurred as a single step, clones of DES-4 cells cotransfected with pSV2-neo and HaMSV DNAs were selected by antibiotic resistance and characterized. There was a good correlation between tumorigenicity and expression of v-Ha-ras DNA; however, the clones were highly variable in terms of their latency periods in vivo and anchorage-independent growth. Neither of these two parameters correlated with the level of expression of v-Ha-ras RNA. All of the cell lines derived from tumors and reinoculated into nude mice had short latency periods in vivo, were highly anchorage independent, and had high levels of v-Ha-ras expression. These results suggest that, in these experiments, v-Ha-ras expression was necessary, but not sufficient, for the tumorigenicity of DES-4 cells and that additional changes in the cells were acquired.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2981612

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  17 in total

1.  Cooperative transforming activities of ras, myc, and src viral oncogenes in nonestablished rat adrenocortical cells.

Authors:  A MacAuley; T Pawson
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

2.  Activated v-myc and v-ras oncogenes do not transform normal human lymphocytes.

Authors:  M Stevenson; D J Volsky
Journal:  Mol Cell Biol       Date:  1986-10       Impact factor: 4.272

3.  Loss of tumor-suppressive function during chemically induced neoplastic progression of Syrian hamster embryo cells.

Authors:  M Koi; J C Barrett
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

4.  Role of a tumor-suppressor gene in the negative control of anchorage-independent growth of Syrian hamster cells.

Authors:  M Koi; C A Afshari; L A Annab; J C Barrett
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

5.  Differential response to retinoic acid of Syrian hamster embryo fibroblasts expressing v-src or v-Ha-ras oncogenes.

Authors:  A M Jetten; J C Barrett; T M Gilmer
Journal:  Mol Cell Biol       Date:  1986-10       Impact factor: 4.272

6.  Synergism of v-myc and v-Ha-ras in the in vitro neoplastic progression of murine lymphoid cells.

Authors:  R C Schwartz; L W Stanton; S C Riley; K B Marcu; O N Witte
Journal:  Mol Cell Biol       Date:  1986-09       Impact factor: 4.272

Review 7.  Cellular proliferation and lipid metabolism: importance of lipoxygenases in modulating epidermal growth factor-dependent mitogenesis.

Authors:  T E Eling; W C Glasgow
Journal:  Cancer Metastasis Rev       Date:  1994-12       Impact factor: 9.264

8.  Regulation of microfilament organization and anchorage-independent growth by tropomyosin 1.

Authors:  J Boyd; J I Risinger; R W Wiseman; B A Merrick; J K Selkirk; J C Barrett
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

9.  Tumor formation by a murine macrophage cell line immortalized in vitro by v-raf and v-myc oncogenes.

Authors:  E Blasi; L Varesio; R H Wiltrout
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

10.  Oncogenicity of AKR mink cell focus-inducing murine leukemia virus correlates with induction of chronic phosphatidylinositol signal transduction.

Authors:  A M al-Salameh; M W Cloyd
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.